# Genomic Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genomic-health

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.genomichealth.com
- Total disclosed funding: $70M
- Latest round: Series E (Feb 4, 2004)
- Investors on record: 7

## About

Based in CA, US, and founded in 1995, Genomic Health, Inc. is a diagnostic test company. In November 2019, it combined with Genomic Health, creating a leading global cancer diagnostics company.

The company is engaged in genomic-based diagnostic tests that help optimize cancer care, including addressing the overtreatment of the disease. It has developed an Oncotype IQ® Genomic Intelligence Platform to lead the translation of clinical and genomic data into actionable results for treatment planning throughout the cancer patient journey, from diagnosis to treatment selection and monitoring. The Oncotype IQ portfolio of genomic tests and services has been used to guide treatment decisions for over 1 million cancer patients worldwide.

## Funding rounds

- Series E, Feb 4, 2004, $28M — CHL Medical Partners, Kleiner Perkins, TPG, Versant Ventures, Incyte Corporation
- Series C, Mar 1, 2001, $5M — Targeted Technology
- Series B, Jan 1, 2001, $29M — Kleiner Perkins, Versant Ventures, Baker-Tisch Investments
- Series A, Nov 1, 2000, $7.9M — CHL Medical Partners

## Investors

- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series A, Series E
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B, Series E
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series E
- Baker-Tisch Investments — Series B
- Targeted Technology (https://capitalatlas.ai/funds/targeted-technology) — Series C
- TPG (https://capitalatlas.ai/funds/tpg) — Series E
- Incyte Corporation — Series E